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Figure 1. S1PR3 mediates acute mechanical pain. (A) von Frey 50% withdrawal threshold measurements for S1pr3+/+ (WT, N = 8), S1pr3+/- (HET, N = 7)
and S1pr3-/- (KO, N = 12) mice. p<0.0001 (one-way ANOVA). Tukey-Kramer post hoc comparisons for KO and HET to WT indicated on graph. (B) von
Frey force-response graph for WT (N = 8) versus KO (N = 12) animals; pgenotype <0.0001 (two-way ANOVA). Tukey HSD comparisons between
genotypes are indicated for given forces. (C) % withdrawal to pinprick stimulation of hindpaw for HET versus KO animals; p<0.0001 (unpaired t-test;
N = 5–7 mice per group). (D) Number of attempted removal bouts in tape assay for WT (N = 2), HET (N = 2), and KO (N = 5) mice; p=0.172 (one-way
ANOVA). (E) Baseline radiant heat measurements for WT (N = 8), HET (N = 3), and KO (N = 5) mice; p=0.444 (one-way ANOVA). (F) von Frey 50%
withdrawal threshold measurements for mice pre- and post-injection of 500 mM TY 52156 (N = 10), 10 mM W146 (N = 6), or 1% DMSO-PBS vehicle
(N = 17); p=0.016, 0.650 (two-tailed paired t-test comparing vehicle- vs. drug-injected paw). (G) von Frey force-response graph for mice injected with
either 1% DMSO-PBS (N = 4) or 500 mM TY 52156 (N = 4); ptreatment <0.0001 (two-way ANOVA). Tukey HSD comparisons were made between treatment
groups and significant differences at a given force are indicated on graph. Error bars represent mean ± SD.
DOI: https://doi.org/10.7554/eLife.33285.002
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Figure 1—figure supplement 1. Loss of S1PR3 selectively impairs mechanonociception. Related to Figure 1. (A) Time to righting in seconds for P7
pups per genotype for WT and KO mice; p=0.575 (two-tailed unpaired t-test; N = 7 mice per genotype). (B) (Left) Time spent scratching in response to
injection of 50 mM chloroquine or PBS vehicle (VEH) in WT and KO mice; p=0.36, 0.98, (unpaired t-tests; N = 3–4 mice per group). (Right) Time spent
scratching in response to injection of 27 mM Histamine or 0.1% DMSO-PBS in WT and KO mice; p=0.51, 0.06 (unpaired t-tests; N = 3–4 mice per
group). (C) Normalized paw withdrawal latencies post-injection of SKI II, TY 52156, or 0.1% DMSO-PBS vehicle into the hind paw of wild-type animals;
p=0.65 (one-way ANOVA; N = 5 mice per group). Unless otherwise indicated, error bars represent mean ± SD.
DOI: https://doi.org/10.7554/eLife.33285.003
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Figure 2. Endogenous S1P mediates acute mechanical pain. (A) von Frey 50% withdrawal measurements for mice pre- and post-injection of 50 mM SKI
II (N = 8) or 10 mM S1P (N = 7); p=0.003, 0.604 (two-tailed paired t-tests). (B) von Frey force-response graph for animals injected with 10 mM S1P or 0.1%
MeOH-PBS; pgenotype >0.05 (two-way ANOVA; N = 8 mice per group). No Tukey HSD comparisons at any force between genotypes were significant. (C)
Intradermal cheek injection of 10 mM S1P, 2 mM, 0.2 mM, and 20 mL 0.3% methanol PBS (vehicle), with quantification of number of forepaw wipes over
the 5 min post-injection interval; p<0.0001 (one-way ANOVA; N = 3 mice per condition). Dunnett’s multiple comparisons p-values are represented on
graph for comparisons made between treated and vehicle groups. (D) Radiant heat normalized paw withdrawal latencies 20–30 min post injection of 15
mL 10 mM S1P, 0.2 mM S1P. or 0.3% methanol-PBS vehicle (i.d.) into the hind paw of S1PR3 WT or KO mice; p=0.0129 (one-way ANOVA; N = 3–10 mice
per condition). Dunnett’s multiple comparisons p-values are represented on graph for comparisons made between treated and vehicle groups. (E) von
Figure 2 continued on next page
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Figure 2 continued
Frey 50% withdrawal measurements for mice pre- (baseline) and post-injection of 50 mM SKI II (N = 14) and 0 (N = 4), 10 (N = 3), 75 (N = 4), or 200 nM
S1P (N = 3; one-way ANOVA; p=0.0001). Tukey Kramer comparisons are indicated on graph. Error bars represent mean ± SD.
DOI: https://doi.org/10.7554/eLife.33285.005
Hill et al. eLife 2018;7:e33285. DOI: https://doi.org/10.7554/eLife.33285 5 of 20
Research article Neuroscience
Figure 3. S1pr3 is expressed in A mechanonociceptors and C thermal nociceptors. (A) (Top) Representative co-ISH of S1pr3 (green; left) with Scn1a,
Npy2r, Piezo2, and Trpv1 (magenta; center) in sectioned DRG. Right column: overlay with co-localized regions colored white (10x air objective;
Figure 3 continued on next page
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Figure 3 continued
scale = 100 mm). (B) Bar chart showing the % of total cells expressing the indicated marker (grey) and the % of total cells co-expressing both marker and
S1pr3 (green). See Table S1 for quantification. (C) Representative IHC images of sectioned DRG from S1pr3mCherry/+ animals stained with anti-DsRed
(green, S1PR3) and anti-Peripherin (left, magenta) or anti-NF200 (right, magenta). Arrows indicate co-stained cells. Images were acquired using a 10x air
objective (scale = 100 mm). (D) Whole-mount skin IHC confocal images with anti-DsRed antibody (S1PR3, green) and anti-NefH antibody (NF200,
magenta) in an S1pr3mCherry/+ animal (20x water objective; scale = 50 mm). Arrows indicate co-positive free nerves (left image). Arrowheads indicate
NF200- free nerves (left) or S1PR3- circumferential fibers (right image). (E) Sectioned skin IHC with anti-DsRed (S1PR3) and anti-NefH (NF200, left, top
right) or anti-DsRed (S1PR3) and anti-beta-tubulin III (BTIII, bottom right) antibody (magenta) in S1pr3mCherry/+ skin (20x air objective; scale = 50 mm).
Arrows indicate co-positive free nerve endings (left), S1PR3-negative lanceolate/circumferential hair follicle endings (top right, arrow = circumferential,
arrowhead = lanceolate), or S1PR3-negative putative Merkel afferent (bottom right). (F) (Left) Quantification of sectioned DRG IHC experiments showing
% of S1PR3+ cells that co-stained with indicated markers (n > 250 cells per marker). (Right) Quantification of sectioned skin IHC experiments showing %
of fibers positive for indicated marker that co-stained with S1PR3 (anti-DsRed; n = 10 images per marker from two animals).
DOI: https://doi.org/10.7554/eLife.33285.007
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Figure 3—figure supplement 1. S1PR3 KO animals display normal representation of somatosensory neuronal subtypes. Related to Figure 3. (A) ISH of
sectioned adult DRG from WT and S1PR3 KO animals showing specificity of S1pr3 probes (20x air objective, scale = 50 mm). (B) (Image) Representative
Figure 3—figure supplement 1 continued on next page
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Figure 3—figure supplement 1 continued
ISH Trpv1 (top) and Trpa1 (bottom) from sectioned DRG of wild-type (left) and S1PR3 KO animals (right; 20x air objective; scale = 50 mm). (C) % of total
cells expressing Trpv1 and Trpa1 in sectioned DRG of wild-type and S1PR3 KO animals. (D) (Left) Average diameter ± SEM of all cells in sectioned DRG
from WT and S1PR3 KO animals (p=0.36, two-tailed t-test; n = 437 and 679 cells from two animals each, respectively). (Right) Average diameter ±SD of
Trpv1+ cells in WT and S1PR3 KO DRG (p=0.63, two-tailed t-test; n = 127 and 85 cells, respectively). (E) Representative staining with anti-S1PR3
antibody (1:2000) in sectioned adult DRG from WT and S1PR3 KO animals (10x air objective, scale = 100 mm). (F) Representative IHC images of
sectioned DRG from S1PR3 KO animals stained with anti-DsRed (green) and anti-Peripherin (left, magenta) or anti-NF200 (right, magenta). Images were
acquired using a 10x air objective (scale = 100 mm). (G) (Left) Quantification of total percentage of cells stained with indicated markers in sectioned
DRG from S1pr3mCherry/+ and S1PR3 KO animals (n > 250 cells per condition). (Right) Average diameter of anti-NF200 +cells in S1pr3mCherry/+ and S1PR3
KO DRG (p=0.15, two-tailed t-test; n = 256 and 194 cells, respectively). (H) Percent responders to S1P and capsaicin in ratiometric calcium imaging of
wild-type and S1PR3 KO cultured DRG and TG neurons; p<0.0001 (one-way ANOVA; N = 2 DRG and 2 TG preparations of 8 wells each). Sidak’s
multiple comparisons p-values are represented on graph for comparisons made between genotypes. Error bars represent mean ± SEM. (I) (Left) No
primary control showing robust staining of hair follicles in whole mount skin in contrast to specific neuronal staining shown in Figure 3D. (Right) No
primary control showing staining around hair follicles and in epidermis in sectioned skin. Scale = 50 mm (20x water objective).
DOI: https://doi.org/10.7554/eLife.33285.008
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Figure 4. S1P activates thermal nociceptors but not mechanonociceptors. (A) (Left) Representative image of mCherry signal in live, cultured adult DRG
neurons from one S1pr3mCherry/+ animal. (Right) Quantification of % of total cells expressing S1pr3 from DRG ISH and mCherry from dissociated DRG
cultures (N = 2 animals each experiment). (B) Representative traces depicting F340/F380 signal from Fura2-AM calcium imaging showing two neurons,
one which responded to 1 mM S1P, 1 mM Capsaicin, and high K + Ringer’s (red) and one which only responded to high K+ (black). (C) (Left) Fura-2 AM
calcium imaging before (left) and after (center) addition of 1 mM S1P in S1pr3 mCherry/+ cultured mouse DRG neurons. Bar indicates fluorescence ratio.
Right-hand image indicates mCherry fluorescence. (Right) % of mCherry neurons that are responsive to 1 mM S1P in ratiometric calcium imaging
(n > 1000 cells from 16 imaging wells from three animals). (D) Dose-response curve of mean neuronal calcium responders to varying concentrations of
S1P. Concentrations used: 1, 10, 50, 100, 200, 1000, and 10,000 nanomolar (N = 2 animals). Error bars represent mean ± SD. Black dotted line indicates
sigmoidal fit for all S1P responders from which EC50 was derived. All S1P responders were also capsaicin-responsive. (E) Current-clamp trace of a single
wild-type neuron firing action potentials in response to bath addition of 1 mM S1P and 1 mM capsaicin, with Ringer’s wash in-between. Four of
tenneurons responded to S1P and one of one S1P-responsive also responded to capsaicin. Bar = 2 s. (F) (Left) Fura-2 AM calcium imaging after
addition of 500 nM Hm1a in S1pr3mCherry/+ P0 TG neurons, which were used instead of adult DRG neurons because they respond to Hm1a without prior
PGE2 sensitization. Right-hand image indicates mCherry fluorescence. (Right) % of Hm1a-responsive P0 TG neurons that are mCherry+ (N = 1 animal,
1230 total neurons).
DOI: https://doi.org/10.7554/eLife.33285.009
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Figure 5. S1PR3 modulates KCNQ2/3 channels to regulate AM excitability. All experiments were performed in S1pr3mCherry/+ or -/- DRG neurons. (A)
(Left) Example traces of a single mCherry +neuron in whole cell current clamp before and after S1P application. (Right) % change in rheobase after S1P
application for S1pr3mCherry/+ (left, n = 7) and KO (right, n = 12) neurons (pWT,KO = 0.012, 0.287; two-tailed paired t-tests). (B) % D in input resistance
after S1P or vehicle application (p=0.017; two-tailed paired t-test; n = 4 cells per group). (C) The S1P-sensitive current is carried by potassium. The
current-voltage relationship was determined by subtraction of the post-S1P current from the pre-S1P current and reverses at  60.125 mV; n = 6 cells.
Data were fitted with a Boltzmann equation. Pre- and post-S1P currents were measured at the indicated voltage ( 100 mV to +80 mV, 20 mV
increments) following a +100 mV step (100 ms). Current was quantified using the peak absolute value of the slowly-deactivating current 0–10 ms after
stepping to indicated voltage. Unless indicated otherwise, all error bars represent mean ± SEM. (D) (Graphic, top) Averaged current traces of a single
mCherry+ neuron in whole cell voltage clamp recording comparing tail currents (DI tail) pre- and post-S1P using indicated voltage step protocol.
(graphic, bottom) Averaged current traces of a single mCherry+ neuron in whole cell voltage clamp recording with XE991 treatment. Holding phase
( 40 mV, 150 ms) was truncated in traces. (Left graph) % D in outward tail current (average ±SD after indicated treatments (1 mM S1P, 3 mM XE 991, or
both) for S1pr3mCherry/+ medium-diameter neurons; (p=0.58; one-way ANOVA; n = 6, 8, 14 cells) using protocol depicted at right. (Right graph) % D in
inward tail current after indicated treatments (LINO = 100 mM linopirdine) for S1pr3mCherry/+ medium-diameter neurons; (p=0.47; two-tailed paired t-
test; n = 12 cells).
DOI: https://doi.org/10.7554/eLife.33285.010
Hill et al. eLife 2018;7:e33285. DOI: https://doi.org/10.7554/eLife.33285 11 of 20
Research article Neuroscience
Figure 5—figure supplement 1. S1P selectively modulates potassium tail currents to increase DRG neuron excitability. Related to Figure 5. (A) (Left)
Example trace of a single mCherry+ neuron in S1P before and after current injection. (Right) Resting membrane potential (RMP) in millivolts before and
Figure 5—figure supplement 1 continued on next page
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Figure 5—figure supplement 1 continued
after addition of S1P (p=0.23; two-tailed paired t-test; n = 6 cells). (B) Rheobase pre- and post-S1P application in DRG neurons; pWT = 0.011; pKO = 0.28
(two-tailed paired t-test). Same data are represented in Figure 5A. (C) Sodium I-V relationship for a representative S1pr3mCherry/+ medium-diameter
neuron pre- and 5 min post- 1 mM S1P using voltage step from  100 to +80 mV (150 ms steps,  80 mV holding). (D) Steady-state I-V relationship for
same neuron. (E) (Left) % D in peak sodium current (Na+) after S1P or 1% DMSO vehicle application for medium-diameter mCherry+ neurons; p=0.39
(two-tailed paired t-test; n = 7 cells per group). (Right) % D in peak steady-state current (S.S. K+) after S1P or 1% DMSO vehicle application for medium-
diameter mCherry+ neurons; p=0.948 (two-tailed paired t-test; n = 7 cells per group). (F) % D in inward tail current (DI tail) after S1P or 1% DMSO vehicle
application for S1pr3mCherry/+ and KO medium-diameter neurons using a pre-pulse stimulation of +80 mV followed by a step to  80 mV, where (DI tail)
was calculated by subtracting the steady-state current from the absolute peak of the slowly-deactivating current at  80 mV (p=0.014; one-way ANOVA;
n = 10, 13, 10 cells). Tukey Kramer post hoc p-values indicated on graph. (G) Dose-response relationship between % D in tail current and S1P
concentration for 1 nM, 50 nM, 100 nM, and 1 mM S1P (n = 7 cells). EC50 (48.8 nM), marked by thin dotted lines, was estimated from sigmoidal fit (thick
dotted line).
DOI: https://doi.org/10.7554/eLife.33285.011
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Figure 6. S1PR3 is required for nociceptive responses of high-threshold AM nociceptors. (A) (Left) Representative traces of AM fiber activity over time in
ex vivo skin-saphenous nerve recording in response to stimulation (128 mN, top) from HET (middle) and KO (bottom) mice. (Right) Mean firing rate of
Figure 6 continued on next page
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Figure 6 continued
AM fibers in response to force controlled stimulation (4, 8, 16, 32, 64, 128, 256 mN). **p=0.001, ***p=0.0002 (two-way ANOVA, Sidak’s post-hoc); lines,
linear regression (HET: slope = 50 Hz/N, R2 = 0.99; KO: slope = 35 Hz/N, R2 = 0.95). (B) von Frey threshold of AM fibers in S1PR3 HET and KO
specimens. ***p<0.0001 (Mann-Whitney test); lines, median; boxes, 25–75 percentile; whiskers, min-max. (C) Cumulative response plot of AM fibers to
force controlled stimulation (solid lines); four-parameter logistic fit from which half-maximal force was estimated for each genotype (dotted lines). (D)
Conduction velocity (CV) of AM fibers in S1PR3 HET and KO mice. p=0.65 (two-tailed t-test); n = 40, 36 fibers; errors, mean ± SEM. (E) Representative
traces and binned instantaneous firing frequencies (IFF; 200 ms bins) of Non-Adapting and Adapting AMs in response to force controlled stimulation
(256 mN, top) for S1PR3 HET and KO mice; blue regions, dynamic phase of stimulation (200 ms). (F). Proportion of fibers classified by pattern of
mechanically evoked responses to 256-mN stimuli: Non-Responder (HET, 2/40 fibers; KO 5/36), Non-Adapting AM (HET, 18/40; KO, 29/36), Adapting
AM (HET, 20/40; KO, 2/36). Non-Responders fired action potentials to large magnitude von Frey monofilaments (<0.5 mm tip diameter), but not
controlled mechanical stimulation (256 mN, 2 mm tip diameter). ***p<0.00001 (Chi-square test).
DOI: https://doi.org/10.7554/eLife.33285.013
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Figure 6—figure supplement 1. S1PR3 HET AM nociceptors display normal nociceptive responses. Related to Figure 6. (A) Mean firing rate of AM
fibers in response to force controlled stimulation (4, 8, 16, 32, 64, 128, 256 mN) from Figure 6A, with additional data from one wild-type animal
Figure 6—figure supplement 1 continued on next page
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Figure 6—figure supplement 1 continued
(nWT = 4 fibers) (WT: slope, 57 Hz/N, R (Vriens et al., 2011), 0.98; p=0.90, two-way ANOVA comparing HET and WT). (B) (Left) Conduction velocities
from teased fibers from 6 S1PR3 KO animals (purple, Ab, centroid = 13.1 m/s; yellow, Ad, centroid = 5.7 m/s; orange, C, centroid = 0.4 m/s; R2 = 0.69,
N = 65 fibers). (Right) Conduction velocities from teased fibers from 1 S1PR3 HET and 6 C57BL/6 WT animals (purple, Ab, centroid = 14.5 m/s; yellow,
Ad, centroid = 6.8 m/s; orange, C, centroid = 0.3 m/s; R2 = 0.82, N = 76 fibers). Three-term Gaussian model. X-axis plotted on a log 1.2 scale. (C) Mean
firing rates during dynamic (ramp) and static (hold) stimulation for S1PR3 HET and S1PR3 KO recordings (left, Adapting AMs; right, Non-Adapting AMs;
see Figure 6E–F for experimental details). No significant differences were found between genotypes (p=0.227, 0.490 (two-way ANOVA); bars, means).
As shown in Figure 6F, the proportion of Adapting AMs was significantly lower in S1PR3 KO recordings compared with littermate controls.
DOI: https://doi.org/10.7554/eLife.33285.014
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Figure 7. S1PR3 is dispensable for development of chronic mechanical hypersensitivity. (A) Thermal latency before and after CFA treatment (indicated
by dotted line); pgenotype = 0.0053 (two-way ANOVA; N = 5 mice per genotype). Sidak’s multiple comparison between genotypes for specific time
points indicated on graph. Error bars represent mean ± SD. (B) (Left) Normalized 50% withdrawal threshold before and after CFA treatment (indicated
by dotted line); p(genotype)<0.001 (two-way ANOVA). (Right) 50% withdrawal thresholds for same experiment (p(genotype)=0.1634; two-way ANOVA).
(C) (Left) Thermal latency assessed before (‘Baseline’) and 24 hr post CFA injection with either vehicle (CFA + VEH) or TY 52156 (CFA + TY) acutely
administered; p<0.0001 (one-way ANOVA N = 5 mice per treatment). (Right) Thermal latency assessed before and after CFA injection with either
vehicle (CFA + VEH) or SKI II (CFA + SKI II) acutely administered on Day 1; p<0.0001 (one-way ANOVA; N = 5–7 mice per treatment). Dunnett’s test
comparisons to baseline are indicated on graph. Error bars represent mean ± SD. (D) (Left) 50% withdrawal threshold assessed before and 24 hr post
CFA injection with either vehicle (CFA + VEH) or TY 52156 (CFA + TY) acutely administered on Day 1; p<0.0001 (one-way ANOVA; N = 5 mice per
treatment). Dunnett’s test comparisons to baseline are indicated on graph. (Right) 50% withdrawal threshold assessed before and 24 hr post CFA
injection with either vehicle (CFA + VEH) or SKI II (CFA + SKI II) acutely administered; p-values indicated on graph (two-tailed unpaired t-test; N = 5
mice per group.
DOI: https://doi.org/10.7554/eLife.33285.016
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Figure 7—figure supplement 1. S1PR3 KO animals display normal CFA-evoked immune cell recruitment. Related
to Figure 7. (A) Recruitment of neutrophils (Neut.) or inflammatory monocytes (IMs) to hindpaw skin 24 hr post-
CFA administration in S1PR3 HET and KO mice, as a dot plot of CD11b + cells plotting Ly6G fluorescence
intensity vs. Ly6C intensity (AFU). Boxes are for illustrative purposes. (B) Recruitment of immune cells, including
neutrophils (Neut.) and inflammatory monocytes (IMs) to hindpaw skin 24 hr post-CFA administration in HET and
KO mice, displayed as total number of cells; N = 8 mice per genotype. Sidak’s multiple comparisons were made
between HET and KO for each cell type.
DOI: https://doi.org/10.7554/eLife.33285.017
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Figure 8. Proposed model illustrating a key role for S1PR3 in regulating mechanical pain in AM nociceptors. (Top) S1P promotes activation of S1PR3,
which leads to inhibition of KCNQ2/3 currents and promotes normal mechanical pain sensitivity. (Bottom) Diminished S1P or S1PR3 antagonism
alleviates inhibition of KCNQ2/3, leading to mechanical pain hyposensitivity.
DOI: https://doi.org/10.7554/eLife.33285.019
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